{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:12Z","timestamp":1789679052013,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T00:00:00Z","timestamp":1201564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T00:00:00Z","timestamp":1201564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/ncpcardio1110","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T06:59:55Z","timestamp":1201589995000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression"],"prefix":"10.1038","volume":"5","author":[{"given":"Andre","family":"Keren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Syrris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,29]]},"reference":[{"key":"BFncpcardio1110_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P  et al. (1996) Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841\u2013842","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ  et al. (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study (Coronary Artery Risk Development in [Young] Adults). Circulation 92: 785\u2013789","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR3","first-page":"2863","volume-title":"The Metabolic and Molecular Bases of Inherited Diseases","author":"JL Goldstein","year":"2001","unstructured":"Goldstein JL (2001) Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Diseases, edn 8, 2863\u20132913 (Eds Scriver CS.  et al.) New York, NY: McGraw-Hill Book Co"},{"key":"BFncpcardio1110_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar AK and Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4: 214\u2013225","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"BFncpcardio1110_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/hrt.77.2.130","volume":"77","author":"WJ McKenna","year":"1997","unstructured":"McKenna WJ  et al. (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77: 130\u2013132","journal-title":"Heart"},{"key":"BFncpcardio1110_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.1996.03540030033028","volume":"276","author":"BJ Maron","year":"1996","unstructured":"Maron BJ  et al. (1996) Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 276: 199\u2013204","journal-title":"JAMA"},{"key":"BFncpcardio1110_CR7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","volume":"36","author":"PM Elliott","year":"2000","unstructured":"Elliott PM  et al. (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36: 2212\u20132218","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/hrt.2005.068577","volume":"92","author":"PM Elliott","year":"2006","unstructured":"Elliott PM  et al. (2006) Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 92: 785\u2013791","journal-title":"Heart"},{"key":"BFncpcardio1110_CR9","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","volume":"363","author":"P Elliott","year":"2004","unstructured":"Elliott P and McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 363: 1881\u20131891","journal-title":"Lancet"},{"key":"BFncpcardio1110_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0735-1097(88)90101-5","volume":"11","author":"WJ McKenna","year":"1988","unstructured":"McKenna WJ  et al. (1988) Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol 11: 351\u2013358","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","volume":"104","author":"JG Seidman","year":"2001","unstructured":"Seidman JG and Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104: 557\u2013567","journal-title":"Cell"},{"key":"BFncpcardio1110_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1152\/physrev.00012.2002","volume":"82","author":"D Fatkin","year":"2002","unstructured":"Fatkin D and Graham RM (2002) Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82: 945\u2013980","journal-title":"Physiol Rev"},{"key":"BFncpcardio1110_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","volume":"88","author":"AM Varnava","year":"2001","unstructured":"Varnava AM  et al. (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88: 275\u2013279","journal-title":"Am J Cardiol"},{"key":"BFncpcardio1110_CR14","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"P Richard","year":"2003","unstructured":"Richard P  et al. (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227\u20132232","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","volume":"33","author":"AJ Marian","year":"2001","unstructured":"Marian AJ and Roberts R (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33: 655\u2013670","journal-title":"J Mol Cell Cardiol"},{"key":"BFncpcardio1110_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1161\/01.CIR.101.12.1396","volume":"101","author":"JA Moolman","year":"2000","unstructured":"Moolman JA  et al. (2000) A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation 101: 1396\u20131402","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1586\/14737159.6.1.65","volume":"6","author":"P Charron","year":"2006","unstructured":"Charron P and Komajda M (2006) Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease. Expert Rev Mol Diagn 6: 65\u201378","journal-title":"Expert Rev Mol Diagn"},{"key":"BFncpcardio1110_CR18","first-page":"e858","volume":"113","author":"CY Ho","year":"2006","unstructured":"Ho CY and Seidman CE (2006) A contemporary approach to hypertrophic cardiomyopathy. Circulation 113: e858\u2013e862","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.272.5262.731","volume":"272","author":"AA Geisterfer-Lowrance","year":"1996","unstructured":"Geisterfer-Lowrance AA  et al. (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731\u2013734","journal-title":"Science"},{"key":"BFncpcardio1110_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","volume":"104","author":"SF Nagueh","year":"2001","unstructured":"Nagueh SF  et al. (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104: 128\u2013130","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1172\/JCI200214677","volume":"109","author":"C Semsarian","year":"2002","unstructured":"Semsarian C  et al. (2002) The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest 109: 1013\u20131020","journal-title":"J Clin Invest"},{"key":"BFncpcardio1110_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","volume":"103","author":"DS Lim","year":"2001","unstructured":"Lim DS  et al. (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103: 789\u2013791","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","volume":"321","author":"JA Jarcho","year":"1989","unstructured":"Jarcho JA  et al. (1989) Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321: 1372\u20131378","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","volume":"62","author":"AA Geisterfer-Lowrance","year":"1990","unstructured":"Geisterfer-Lowrance AA  et al. (1990) A molecular basis for familial hypertrophic cardiomyopathy: a \u03b2-cardiac myosin heavy chain gene missense mutation. Cell 62: 999\u20131006","journal-title":"Cell"},{"key":"BFncpcardio1110_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","volume":"326","author":"H Watkins","year":"1992","unstructured":"Watkins H  et al. (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108\u20131114","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1136\/heart.89.10.1179","volume":"89","author":"A Woo","year":"2003","unstructured":"Woo A  et al. (2003) Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 89: 1179\u20131185","journal-title":"Heart"},{"key":"BFncpcardio1110_CR27","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","volume":"338","author":"H Niimura","year":"1998","unstructured":"Niimura H  et al. (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248\u20131257","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/euhj.1997.0575","volume":"19","author":"P Charron","year":"1998","unstructured":"Charron P  et al. (1998) Genotype\u2013phenotype correlations in familial hypertrophic cardiomyopathy: a comparison between mutations in the cardiac protein- C and the \u03b2-myosin heavy chain genes. Eur Heart J 19: 139\u2013145","journal-title":"Eur Heart J"},{"key":"BFncpcardio1110_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/hc0402.102990","volume":"105","author":"H Niimura","year":"2002","unstructured":"Niimura H  et al. (2002) Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446\u2013451","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR30","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","volume":"332","author":"H Watkins","year":"1995","unstructured":"Watkins H  et al. (1995) Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058\u20131064","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0735-1097(96)00530-X","volume":"29","author":"JC Moolman","year":"1997","unstructured":"Moolman JC  et al. (1997) Sudden death due to troponin T mutations. J Am Coll Cardiol 29: 549\u2013555","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR32","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/hc3701.095952","volume":"104","author":"AM Varnava","year":"2001","unstructured":"Varnava AM  et al. (2001) Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104: 1380\u20131384","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ng0897-379","volume":"16","author":"A Kimura","year":"1997","unstructured":"Kimura A  et al. (1997) Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379\u2013382","journal-title":"Nat Genet"},{"key":"BFncpcardio1110_CR34","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1006\/jmcc.2000.1204","volume":"32","author":"TM Olson","year":"2000","unstructured":"Olson TM  et al. (2000) Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1687\u20131694","journal-title":"J Mol Cell Cardiol"},{"key":"BFncpcardio1110_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1006\/bbrc.1999.1221","volume":"262","author":"M Satoh","year":"1999","unstructured":"Satoh M  et al. (1999) Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262: 411\u2013417","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpcardio1110_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/humu.1143","volume":"17","author":"B Hoffmann","year":"2001","unstructured":"Hoffmann B  et al. (2001) First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 17: 524","journal-title":"Hum Mutat"},{"key":"BFncpcardio1110_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ng0596-63","volume":"13","author":"K Poetter","year":"1996","unstructured":"Poetter K  et al. (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63\u201369","journal-title":"Nat Genet"},{"key":"BFncpcardio1110_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","volume":"112","author":"E Carniel","year":"2005","unstructured":"Carniel E  et al. (2005) Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112: 54\u201359","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR39","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","volume":"44","author":"SL Van Driest","year":"2004","unstructured":"Van Driest SL  et al. (2004) Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 1903\u20131910","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0092-8674(01)00586-4","volume":"107","author":"JS Davis","year":"2001","unstructured":"Davis JS  et al. (2001) The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell 107: 631\u2013641","journal-title":"Cell"},{"key":"BFncpcardio1110_CR41","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","volume":"107","author":"C Geier","year":"2003","unstructured":"Geier C  et al. (2003) Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107: 1390\u20131395","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR42","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbrc.2006.10.119","volume":"351","author":"JL Theis","year":"2006","unstructured":"Theis JL  et al. (2006) Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun 351: 896\u2013902","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpcardio1110_CR43","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jacc.2004.08.058","volume":"44","author":"T Hayashi","year":"2004","unstructured":"Hayashi T  et al. (2004) Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44: 2192\u20132201","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR44","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2006.04.151","volume":"345","author":"VC Vasile","year":"2006","unstructured":"Vasile VC  et al. (2006) A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem Biophys Res Commun 345: 998\u20131003","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpcardio1110_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ymgme.2005.08.006","volume":"87","author":"VC Vasile","year":"2006","unstructured":"Vasile VC  et al. (2006) Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab 87: 169\u2013174","journal-title":"Mol Genet Metab"},{"key":"BFncpcardio1110_CR46","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","volume":"103","author":"K Haghighi","year":"2006","unstructured":"Haghighi K  et al. (2006) A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci USA 103: 1388\u20131393","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpcardio1110_CR47","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","volume":"100","author":"A Osio","year":"2007","unstructured":"Osio A  et al. (2007) Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res 100: 766\u2013768","journal-title":"Circ Res"},{"key":"BFncpcardio1110_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.yjmcc.2007.04.006","volume":"42","author":"AP Landstrom","year":"2007","unstructured":"Landstrom AP (2007) Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol 42: 1026\u20131035","journal-title":"J Mol Cell Cardiol"},{"key":"BFncpcardio1110_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0733-8619(05)70182-1","volume":"18","author":"AA Amato","year":"2000","unstructured":"Amato AA (2000) Acid maltase deficiency and related myopathies. Neurol Clin 18: 151\u2013165","journal-title":"Neurol Clin"},{"key":"BFncpcardio1110_CR50","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B  et al. (2002) Prevalence of Anderson\u2013Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105: 1407\u20131411","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR51","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S and Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656\u20132668","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR52","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M  et al. (2002) PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype\u2013phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70: 1555\u20131563","journal-title":"Am J Hum Genet"},{"key":"BFncpcardio1110_CR53","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.40.9.704","volume":"40","author":"A Sarkozy","year":"2003","unstructured":"Sarkozy A  et al. (2003) Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 40: 704\u2013708","journal-title":"J Med Genet"},{"key":"BFncpcardio1110_CR54","first-page":"581","volume":"7","author":"F Palau","year":"2001","unstructured":"Palau F  et al (2001) Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis. Int J Mol Med 7: 581\u2013589","journal-title":"Int J Mol Med"},{"key":"BFncpcardio1110_CR55","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","volume":"10","author":"E Blair","year":"2001","unstructured":"Blair E  et al. (2001) Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10: 1215\u20131220","journal-title":"Hum Mol Genet"},{"key":"BFncpcardio1110_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI0214571","volume":"109","author":"M Arad","year":"2002","unstructured":"Arad M  et al. (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109: 357\u2013362","journal-title":"J Clin Invest"},{"key":"BFncpcardio1110_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI116957","volume":"93","author":"R Anan","year":"1994","unstructured":"Anan R  et al. (1994) Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 93: 280\u2013285","journal-title":"J Clin Invest"},{"key":"BFncpcardio1110_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/01.CIR.89.1.22","volume":"89","author":"L Fananapazir","year":"1994","unstructured":"Fananapazir L and Epstein ND (1994) Genotype\u2013phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical \u03b2-myosin heavy chain gene mutations. Circulation 89: 22\u201332","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR59","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1073\/pnas.90.9.3993","volume":"90","author":"L Fananapazir","year":"1993","unstructured":"Fananapazir L  et al. (1993) Missense mutations in the \u03b2-myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90: 3993\u20133997","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpcardio1110_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/hrt.82.5.621","volume":"82","author":"A Varnava","year":"1999","unstructured":"Varnava A  et al. (1999) A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 82: 621\u2013624","journal-title":"Heart"},{"key":"BFncpcardio1110_CR61","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1086\/302623","volume":"65","author":"JC Moolman-Smook","year":"1999","unstructured":"Moolman-Smook JC  et al. (1999) The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet 65: 1308\u20131320","journal-title":"Am J Hum Genet"},{"key":"BFncpcardio1110_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.104.522581","volume":"112","author":"HL Tan","year":"2005","unstructured":"Tan HL  et al. (2005). Sudden unexplained death\u2014heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112: 207\u2013213","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR63","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jacc.2004.05.088","volume":"44","author":"J Mogensen","year":"2004","unstructured":"Mogensen J  et al. (2004) Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2315\u20132325","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR64","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1161\/01.CIR.102.16.1950","volume":"102","author":"CY Ho","year":"2000","unstructured":"Ho CY  et al. (2000) Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation 102: 1950\u20131955","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR65","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","volume":"42","author":"J Ingles","year":"2005","unstructured":"Ingles J  et al. (2005) Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 42: e59","journal-title":"J Med Genet"},{"key":"BFncpcardio1110_CR66","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Camisago","year":"2000","unstructured":"Camisago M  et al. (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343: 1688\u20131696","journal-title":"N Engl J Med"},{"key":"BFncpcardio1110_CR67","doi-asserted-by":"publisher","first-page":"H1136","DOI":"10.1152\/ajpheart.2001.280.3.H1136","volume":"280","author":"MC Olsson","year":"2001","unstructured":"Olsson MC  et al. (2001) Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 280: H1136\u2013H1144","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFncpcardio1110_CR68","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","volume":"46","author":"I Olivotto","year":"2005","unstructured":"Olivotto I  et al. (2005) Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46: 480\u2013487","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR69","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/01.CIR.92.7.1808","volume":"92","author":"M Lechin","year":"1995","unstructured":"Lechin M  et al. (1995) Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92: 1808\u20131812","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR70","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1006\/jmcc.1996.0332","volume":"29","author":"F Tesson","year":"1997","unstructured":"Tesson F  et al. (1997) The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 29: 831\u2013838","journal-title":"J Mol Cell Cardiol"},{"key":"BFncpcardio1110_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/heart.87.3.270","volume":"87","author":"JR Ortlepp","year":"2002","unstructured":"Ortlepp JR  et al. (2002) Genetic polymorphisms in the renin\u2013angiotensin\u2013aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 87: 270\u2013275","journal-title":"Heart"},{"key":"BFncpcardio1110_CR72","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/eurheartj\/ehi438","volume":"26","author":"MJ Perkins","year":"2005","unstructured":"Perkins MJ  et al. (2005) Gene-specific modifying effects of pro-LVH polymorphisms involving the renin\u2013angiotensin\u2013aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J 26: 2457\u20132462","journal-title":"Eur Heart J"},{"key":"BFncpcardio1110_CR73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","volume":"60","author":"P Spirito","year":"1987","unstructured":"Spirito P  et al. (1987) Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 60: 123\u2013129","journal-title":"Am J Cardiol"},{"key":"BFncpcardio1110_CR74","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","volume":"46","author":"E Biagini","year":"2005","unstructured":"Biagini E  et al. (2005) Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 46: 1543\u20131550","journal-title":"J Am Coll Cardiol"},{"key":"BFncpcardio1110_CR75","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","volume":"114","author":"KM Harris","year":"2006","unstructured":"Harris KM  et al. (2006) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114: 216\u2013225","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR76","doi-asserted-by":"publisher","first-page":"E112","DOI":"10.1161\/01.CIR.102.17.e112","volume":"102","author":"V Regitz-Zagrosek","year":"2000","unstructured":"Regitz-Zagrosek V  et al. (2000) Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation 102: E112\u2013E116","journal-title":"Circulation"},{"key":"BFncpcardio1110_CR77","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/hmg\/11.20.2499","volume":"11","author":"M Arad","year":"2002","unstructured":"Arad M  et al. (2002) Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 11: 2499\u20132506","journal-title":"Hum Mol Genet"},{"key":"BFncpcardio1110_CR78","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4065\/81.4.459","volume":"81","author":"J Binder","year":"2006","unstructured":"Binder J  et al. (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 81: 459\u2013467","journal-title":"Mayo Clin Proc"},{"key":"BFncpcardio1110_CR79","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.105.563205","volume":"113","author":"SG Priori","year":"2006","unstructured":"Priori SG and Napolitano C (2006) Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation 113: 1130\u20131135","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1038\/ncpcardio1349","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T00:00:00Z","timestamp":1220313600000}}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio1110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:43:51Z","timestamp":1684439031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio1110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,29]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BFncpcardio1110"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio1110","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/ncpcardio1349","asserted-by":"object"}]},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,29]]},"assertion":[{"value":"19 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}